D J Chaplin

3.7k total citations · 2 hit papers
33 papers, 3.0k citations indexed

About

D J Chaplin is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, D J Chaplin has authored 33 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 12 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in D J Chaplin's work include Cancer, Hypoxia, and Metabolism (13 papers), Angiogenesis and VEGF in Cancer (8 papers) and Cancer Treatment and Pharmacology (5 papers). D J Chaplin is often cited by papers focused on Cancer, Hypoxia, and Metabolism (13 papers), Angiogenesis and VEGF in Cancer (8 papers) and Cancer Treatment and Pharmacology (5 papers). D J Chaplin collaborates with scholars based in United Kingdom, United States and Canada. D J Chaplin's co-authors include S A Hill, George R. Pettit, Vivien E. Prise, G. M. Tozer, G. Dark, Gillian M. Tozer, Peggy L. Olive, R E Durand, Eric O. Aboagye and J A Double and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

D J Chaplin

32 papers receiving 2.9k citations

Hit Papers

Guidelines for the welfare and use of animals i... 1997 2026 2006 2016 2010 1997 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D J Chaplin United Kingdom 19 1.4k 1.0k 740 495 482 33 3.0k
Sally A. Hill United Kingdom 29 1.3k 0.9× 866 0.8× 669 0.9× 523 1.1× 471 1.0× 60 2.7k
Dennis F. Deen United States 34 2.2k 1.6× 929 0.9× 763 1.0× 473 1.0× 404 0.8× 141 3.9k
Chryso Kanthou United Kingdom 29 1.7k 1.3× 698 0.7× 614 0.8× 258 0.5× 441 0.9× 61 3.4k
Joseph M. Backer United States 31 1.5k 1.1× 409 0.4× 320 0.4× 687 1.4× 520 1.1× 97 2.9k
Mark C. Lloyd United States 27 1.7k 1.2× 1.2k 1.2× 970 1.3× 299 0.6× 594 1.2× 49 3.5k
Dawen Zhao United States 33 1.3k 0.9× 872 0.8× 581 0.8× 923 1.9× 610 1.3× 73 3.5k
Jonathan W. Wojtkowiak United States 24 2.0k 1.5× 1.6k 1.5× 782 1.1× 252 0.5× 812 1.7× 33 4.0k
H. Charles Manning United States 27 1.6k 1.2× 856 0.8× 993 1.3× 693 1.4× 318 0.7× 73 3.2k
Shawn E. Lupold United States 26 2.6k 1.9× 1.1k 1.0× 798 1.1× 539 1.1× 421 0.9× 58 3.9k
Erina Vlashi United States 25 1.7k 1.2× 1.0k 1.0× 1.3k 1.8× 308 0.6× 261 0.5× 48 3.0k

Countries citing papers authored by D J Chaplin

Since Specialization
Citations

This map shows the geographic impact of D J Chaplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D J Chaplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D J Chaplin more than expected).

Fields of papers citing papers by D J Chaplin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D J Chaplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D J Chaplin. The network helps show where D J Chaplin may publish in the future.

Co-authorship network of co-authors of D J Chaplin

This figure shows the co-authorship network connecting the top 25 collaborators of D J Chaplin. A scholar is included among the top collaborators of D J Chaplin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D J Chaplin. D J Chaplin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Workman, Paul, Eric O. Aboagye, Frances R. Balkwill, et al.. (2010). Guidelines for the welfare and use of animals in cancer research. British Journal of Cancer. 102(11). 1555–1577. 1076 indexed citations breakdown →
3.
Collingridge, David R., S A Hill, & D J Chaplin. (2001). Proportion of infiltrating IgG-binding immune cells predict for tumour hypoxia. British Journal of Cancer. 84(5). 626–630. 11 indexed citations
4.
Pedley, RB, Sally A. Hill, G Boxer, et al.. (2001). Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate.. PubMed. 61(12). 4716–22. 82 indexed citations
5.
Konerding, Moritz A., W Malkusch, E. Fait, et al.. (1999). Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts. British Journal of Cancer. 80(5-6). 724–732. 161 indexed citations
6.
Chaplin, D J, et al.. (1999). The effects of nicotinamide plus carbogen or pions for microscopic SCCVII tumors.. Oncology Reports. 5 indexed citations
7.
Pettit, George R., Delbert L. Herald, D J Chaplin, et al.. (1998). Antineoplastic agents 393. Synthesis of the trans-isomer of combretastatin A-4 prodrug.. PubMed. 13(8). 981–93. 52 indexed citations
8.
Tozer, Gillian M., Vivien E. Prise, & D J Chaplin. (1997). Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine.. PubMed. 57(5). 948–55. 84 indexed citations
9.
Hill, Simon A. & D J Chaplin. (1996). Detection of Microregional Fluctuations in Erythrocyte Flow Using Laser Doppler Microprobes. Advances in experimental medicine and biology. 388. 367–371. 7 indexed citations
10.
Chaplin, D J, et al.. (1996). Early skin response to fractionated doses of pions for determining therapeutic gain factors.. PubMed. 21(2). 69–75. 1 indexed citations
11.
Chaplin, D J, et al.. (1995). Temporal heterogeneity in microregional erythrocyte flux in experimental solid tumours. British Journal of Cancer. 71(6). 1210–1213. 99 indexed citations
12.
Hill, S A, Sarah Lonergan, J. Denekamp, & D J Chaplin. (1994). The Effect of Vinca Alkaloids on Tumour Blood Flow. Advances in experimental medicine and biology. 345. 417–422. 11 indexed citations
13.
Chaplin, D J, et al.. (1991). Possible Mechanisms for Intermittent Blood Flow in the Murine SCCVII Carcinoma. International Journal of Radiation Biology. 60(1-2). 139–146. 35 indexed citations
14.
Chaplin, D J. (1991). The Effect of Therapy on Tumour Vascular Function. International Journal of Radiation Biology. 60(1-2). 311–325. 27 indexed citations
15.
Horsman, Michael R., D J Chaplin, & Jens Overgaard. (1991). The Effect of Combining Flavone Acetic Acid and Hyperthermia on the Growth of a C3H Mammary Carcinomain Vivo. International Journal of Radiation Biology. 60(1-2). 385–388. 8 indexed citations
16.
Korbelik, Mladen, Gorazd Krosl, & D J Chaplin. (1991). Photofrin uptake by murine macrophages.. PubMed. 51(9). 2251–5. 47 indexed citations
17.
Adomat, Hans, et al.. (1990). Toxicity of [PtCl2(NH3)L] in hypoxia; L = misonidazole or metronidazole.. PubMed. 5(1). 121–8. 3 indexed citations
18.
Chaplin, D J, Michael R. Horsman, & Martin J. Trotter. (1990). Effect of Nicotinamide on the Microregional Heterogeneity of Oxygen Delivery Within a Murine Tumor. JNCI Journal of the National Cancer Institute. 82(8). 672–676. 120 indexed citations
19.
Durand, R E & D J Chaplin. (1987). Chemosensitization by misonidazole in CCNU-treated spheroids and tumours. British Journal of Cancer. 56(2). 103–109. 7 indexed citations
20.
Olive, Peggy L. & D J Chaplin. (1986). Oxygen and nitroreductase-dependent binding of af-2 in spheroids and murine tumors. International Journal of Radiation Oncology*Biology*Physics. 12(7). 1247–1250. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026